Intuitive Surgical, Inc. $ISRG Stock: Nelson Capital Management LLC Decreases Stake

Nelson Capital Management LLC lowered its holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 60.7% during the third quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 2,818 shares of the medical equipment provider’s stock after selling 4,349 shares during the quarter. Nelson Capital Management LLC’s holdings in Intuitive Surgical were worth $1,146,000 at the end of the most recent quarter.

Several other institutional investors also recently added to or reduced their stakes in ISRG. Bank of America Corp DE grew its stake in shares of Intuitive Surgical by 3.3% in the first quarter. Bank of America Corp DE now owns 3,616,973 shares of the medical equipment provider’s stock worth $1,667,388,000 after acquiring an additional 116,292 shares during the last quarter. Bank of New York Mellon Corp bought a new position in Intuitive Surgical during the second quarter worth $1,335,753,000. Amundi increased its position in Intuitive Surgical by 8.6% during the first quarter. Amundi now owns 2,428,356 shares of the medical equipment provider’s stock worth $1,119,448,000 after acquiring an additional 193,096 shares during the period. Arrowstreet Capital Limited Partnership raised its stake in Intuitive Surgical by 95.3% during the 1st quarter. Arrowstreet Capital Limited Partnership now owns 2,105,544 shares of the medical equipment provider’s stock valued at $970,635,000 after purchasing an additional 1,027,475 shares during the last quarter. Finally, Sumitomo Mitsui Trust Group Inc. raised its stake in Intuitive Surgical by 10.8% during the 3rd quarter. Sumitomo Mitsui Trust Group Inc. now owns 1,893,485 shares of the medical equipment provider’s stock valued at $769,948,000 after purchasing an additional 184,044 shares during the last quarter. 83.64% of the stock is owned by institutional investors.

Intuitive Surgical Stock Performance

Shares of NASDAQ:ISRG traded up $3.70 during trading on Friday, hitting $443.59. 1,604,248 shares of the stock were exchanged, compared to its average volume of 2,787,457. The company has a market capitalization of $153.77 billion, a price-to-earnings ratio of 53.64, a price-to-earnings-growth ratio of 3.03 and a beta of 1.45. Intuitive Surgical, Inc. has a 1-year low of $328.57 and a 1-year high of $603.88. The company’s fifty day simple moving average is $417.59 and its 200-day simple moving average is $429.98.

Intuitive Surgical (NASDAQ:ISRG) last issued its earnings results on Tuesday, October 20th. The medical equipment provider reported $3.00 EPS for the quarter, beating analysts’ consensus estimates of $2.65 by $0.35. Intuitive Surgical had a return on equity of 18.17% and a net margin of 25.54%. The business had revenue of $3.05 billion during the quarter, compared to analyst estimates of $2.91 billion. During the same period in the prior year, the company posted $2.40 earnings per share. Intuitive Surgical’s revenue was up 21.7% on a year-over-year basis. On average, research analysts forecast that Intuitive Surgical, Inc. will post 9.37 earnings per share for the current fiscal year.

Analyst Ratings Changes

ISRG has been the subject of a number of research reports. Weiss Ratings restated a “hold (c)” rating on shares of Intuitive Surgical in a research report on Thursday. TD Cowen restated a “buy” rating and set a $485.00 price objective on shares of Intuitive Surgical in a report on Monday, October 19th. Barclays reaffirmed an “overweight” rating and set a $500.00 price objective (up from $485.00) on shares of Intuitive Surgical in a research report on Wednesday, October 21st. Wall Street Zen raised shares of Intuitive Surgical from a “hold” rating to a “buy” rating in a research report on Saturday, October 31st. Finally, Sanford C. Bernstein reiterated an “outperform” rating on shares of Intuitive Surgical in a research note on Wednesday, August 12th. One research analyst has rated the stock with a Strong Buy rating, twenty-three have issued a Buy rating, five have issued a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $493.54.

Insider Buying and Selling

In related news, Director Gary S. Guthart sold 20,095 shares of the company’s stock in a transaction dated Friday, October 23rd. The shares were sold at an average price of $451.61, for a total value of $9,075,102.95. Following the sale, the director owned 1,204,530 shares of the company’s stock, valued at $543,977,793.30. The trade was a 1.64% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, SVP Patricia L. Wadors sold 1,078 shares of the company’s stock in a transaction dated Friday, October 23rd. The shares were sold at an average price of $443.80, for a total transaction of $478,416.40. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last quarter, insiders have sold 39,456 shares of company stock worth $17,769,124. Insiders own 0.60% of the company’s stock.

About Intuitive Surgical

Intuitive Surgical develops, manufactures and markets robotic-assisted systems for minimally invasive procedures. Its products include da Vinci surgical systems, which allow surgeons to control instruments and a high-definition vision system from a console, as well as the Ion endoluminal system, designed to assist with minimally invasive lung biopsies. The company also provides instruments, accessories, training and support services for its systems. Its technology is used in a range of surgical specialties, including urology, general surgery and gynecology.